BC Innovations | Sep 17, 2009
Distillery Therapeutics

Indication: Cancer

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Acute myelogenous leukemia (AML) Mitogen-activated protein kinase kinase (MEK); p38 mitogen-activated protein kinase (p38 MAPK; MAPK14); calcium and DAG-regulated guanine nucleotide exchange factor 1...
BC Innovations | Feb 5, 2009
Distillery Therapeutics

Indication: Neurology

This week in therapeutics Indication Target/ marker/ pathway Summary Licensing status Publication and contact information Neurology Parkinson's disease (PD) Calcium and DAG-regulated guanine nucleotide exchange factor 1 (RASGRP1; CALDAG-GEFI); Calcium and DAG-regulated guanine nucleotide exchange...
Items per page:
1 - 2 of 2